Back to Search
Start Over
AIDS-associated lymphomas are efficiently lysed by rituximab
- Source :
- Cancer Weekly. February 11, 2003, 42
- Publication Year :
- 2003
-
Abstract
- 2003 FEB 11 - (NewsRx.com & NewsRx.net) -- 'Rituximab (Mabthera) and alemtuzumab (Campath, Mabcampath) are non-conjugated IgG1 therapeutic monoclonal antibodies directed against the CD20 and CD52 surface antigens respectively. They [...]
- Subjects :
- MabThera (Medication) -- Evaluation -- Product/service Evaluations
Campath (Medication) -- Evaluation -- Product/service Evaluations
Drug therapy
Evaluation
Complications and side effects
Non-Hodgkin lymphomas -- Drug therapy -- Complications and side effects
AIDS (Disease) -- Complications and side effects -- Drug therapy
Non-Hodgkin's lymphomas -- Drug therapy -- Complications and side effects
Subjects
Details
- Language :
- English
- ISSN :
- 15324567
- Database :
- Gale General OneFile
- Journal :
- Cancer Weekly
- Publication Type :
- News
- Accession number :
- edsgcl.97309954